Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 3, 2009, Pages 394-399

  Chen, Yue ^a   Li, Q ^b   Johansen, H ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c HEALTH STATISTICS DIVISION   (Canada)

Author keywords

Age; Cardiac; Comorbidity; COPD; Database; Hospitalization; Lung; Sex

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COR PULMONALE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TIME SERIES ANALYSIS;

AGED; AGED, 80 AND OVER; CANADA; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY HEART DISEASE; REGISTRIES;

EID: 62349086784     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Petty T L. Definition, epidemiology, course, and prognosis of COPD. Clin Cornerstone 2003; 5: 1-10.
2. Geelhoed E A, Brameld K J, Holman C D, Thompson P J. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J 2007; 37: 87-94.
3. Cydulka R K, McFadden E R Jr, Emerman C L, Sivinski L D, Pisanelli W, Rimm A A. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 1807-1812.
4. Wouters E F. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 2003; 97 (Suppl C): S3-S14.
5. Garcia-Aymerich J, Monso E, Marrades R M, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001; 164: 1002-1007.
6. Rennard S I. Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease. Proc Am Thorac Soc 2005; 2: 94-100.
7. Curkendall S M, DeLuise C, Jones J K, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
8. Sidney S, Sorel M, Quesenberry C P Jr, DeLuise C, Lanes S, Eisner M D. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.
9. Soriano J B, Visick G T, Muellerova H, Payvandi N, Hansell A L. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128: 2099-2107.
10. Sin D D, Man S F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
11. Sin D D, Anthonisen N R, Soriano J B, Agusti A G. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
12. Scarduelli C, Ambrosino N, Confalonieri M, et al. Prevalence and prognostic role of cardiovascular complications in patients with exacerbation of chronic obstructive pulmonary disease admitted to Italian respiratory intensive care units. Ital Heart J 2004; 5: 932-938.
13. Holguin F, Folch E, Redd S C, Mannino D M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128: 2005-2011.
14. Charlson M, Szatrowski T P, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
15. Charlson M E, Pompei P, Ales K E, MacKenzie C R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
16. Chen Y, Stewart P, Dales R, Johansen H, Bryan S, Taylor G. Changing age-pattern of hospitalisation risk of chronic obstructive pulmonary disease in men and women in Canada. Age Ageing 2005; 34: 373-377.
17. Connolly M J, Lowe D, Anstey K, Hosker H S, Pearson M G, Roberts C M. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 2006; 61: 843-848.
18. Saynajakangas O, Lampela P, Koiranen M, Keistinen T. Mortality after first hospitalization for chronic obstructive pulmonary disease: changes in 1980-1998. Cent Eur J Public Health 2004; 12: 19-20.
19. Pistelli R, Lange P, Miller D E. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J 2003; 40 (Suppl): S10-S14.
20. Fuso L, Incalzi R A, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98: 272-277.
21. Antonelli Incalzi R, Fuso E, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800.
22. Incalzi R A, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99: 1600-1605.
23. Sin D D, Wu L, Man S F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
24. Sircar K, Hnizdo E, Petsonk E, Attfield M. Decline in lung function and mortality: implications for medical monitoring. Occup Environ Med 2007; 64: 461-466.
25. Agusti A G. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 367-370; discussion 371-372.
26. Sin D D, Man S F. Commentary: fuelling the fire - systemic inflammation and development of lung disease in the general community. Int J Epidemiol 2006; 35: 1008-1010.
27. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138 (5 Pt 2): S419-S420.
28. Liuzzo G. Atherosclerosis: an inflammatory disease. Rays 2001; 26: 221-230.
29. Brevetti G, Piscione F, Silvestro A, et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost 2003; 89: 1058-1063.
30. Librero J, Peiro S, Ordinana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol 1999; 52: 171-179.
31. Jencks S F, Williams D K, Kay T L. Assessing hospital-associated deaths from discharge data. The role of length of stay and co-morbidities. JAMA 1988; 260: 2240-2246.
32. Iezzoni L I, Foley S M, Daley J, Hughes J, Fisher E S, Heeren T. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA 1992; 267: 2197-2203.
33. Saynajakangas O, Kinnunen T, Tuuponen T, Keistinen T. Length of stay and interval to readmission in emergency hospital treatment of COPD. Age Ageing 2004; 33: 567-570.
34. Baker D W, Einstadter D, Husak S S, Cebul R D. Trends in postdischarge mortality and readmissions: has length of stay declined too far? Arch Intern Med 2004; 164: 538-544.
35. Kinnunen T, Saynajakangas O, Tuuponen T, Keistinen T. Impact of comorbidities on the duration of COPD patients' hospital episodes. Respir Med 2003; 97: 143-146.